Tyler J. Goodwin

1.8k total citations · 1 hit paper
16 papers, 1.5k citations indexed

About

Tyler J. Goodwin is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Tyler J. Goodwin has authored 16 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Immunology and 5 papers in Oncology. Recurrent topics in Tyler J. Goodwin's work include Immunotherapy and Immune Responses (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Nanoplatforms for cancer theranostics (3 papers). Tyler J. Goodwin is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Nanoplatforms for cancer theranostics (3 papers). Tyler J. Goodwin collaborates with scholars based in United States, China and Hong Kong. Tyler J. Goodwin's co-authors include Leaf Huang, Rihe Liu, Limei Shen, Lei Miao, Wantong Song, Jun Li, Qi Liu, Kaili Hu, Manisit Das and Jingjing Li and has published in prestigious journals such as Nature Communications, ACS Nano and The Journal of Immunology.

In The Last Decade

Tyler J. Goodwin

16 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap

2018 345 citations Wantong Song, Limei Shen et al. Nature Communications profile →

Peers

Countries citing papers authored by Tyler J. Goodwin

Since Specialization

Citations

This map shows the geographic impact of Tyler J. Goodwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tyler J. Goodwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tyler J. Goodwin more than expected).

Fields of papers citing papers by Tyler J. Goodwin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tyler J. Goodwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tyler J. Goodwin. The network helps show where Tyler J. Goodwin may publish in the future.

Co-authorship network of co-authors of Tyler J. Goodwin

This figure shows the co-authorship network connecting the top 25 collaborators of Tyler J. Goodwin. A scholar is included among the top collaborators of Tyler J. Goodwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tyler J. Goodwin. Tyler J. Goodwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	The Workers Compensation Burden: Does Compensation Status Lead to Increased Utilization of Healthcare Resources Following Foot and Ankle Surgery? 2023 ·Foot & Ankle Orthopaedics ·Tyler J. Goodwin, Andrew Wilson, Jesse F. Doty	1
2	Facile Fabrication of Tumor Redox-Sensitive Nanoassemblies of Small-Molecule Oleate Prodrug as Potent Chemotherapeutic Nanomedicine 2020 ·UNC Libraries ·Dan Liŭ, Tyler J. Goodwin, (unknown), Cong Luo, (unknown), Bingjun Sun, Jin Sun, Zhonggui He	1
3	Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap breakdown → 2018 ·Nature Communications ·Wantong Song, Limei Shen, Ying Wang, Qi Liu, Tyler J. Goodwin, Jingjing Li, (unknown), Tianzhou Liu, Rihe Liu, Leaf Huang	345
4	Nanoparticle Delivery of RIG-I Agonist Enables Effective and Safe Adjuvant Therapy in Pancreatic Cancer 2018 ·Molecular Therapy ·Manisit Das, Limei Shen, Qi Liu, Tyler J. Goodwin, Leaf Huang	77
5	Local Blockade of Interleukin 10 and C-X-C Motif Chemokine Ligand 12 with Nano-Delivery Promotes Antitumor Response in Murine Cancers 2018 ·ACS Nano ·Limei Shen, Jingjing Li, Qi Liu, Wantong Song, Xueqiong Zhang, Karthik Tiruthani, Haiyang Hu, Manisit Das, Tyler J. Goodwin, Rihe Liu, Leaf Huang	102
6	Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy 2017 ·Gut ·Jingying Zhou, Man Liu, Hanyong Sun, Yu Feng, Liangliang Xu, Anthony W.H. Chan, Joanna H. Tong, John Wong, Charing C. N. Chong, Paul B.S. Lai, (unknown), (unknown), Tyler J. Goodwin, Rihe Liu, Leaf Huang, Zhiwei Chen, Joseph J.�Y. Sung, King Lau Chow, Ka‐Fai To, Alfred S.L. Cheng	168
7	Liver specific gene immunotherapies resolve immune suppressive ectopic lymphoid structures of liver metastases and prolong survival 2017 ·Biomaterials ·Tyler J. Goodwin, Limei Shen, Mengying Hu, Jingjing Li, (unknown), (unknown), Rihe Liu, Leaf Huang	50
8	Investigation of phosphorylated adjuvants co-encapsulated with a model cancer peptide antigen for the treatment of colorectal cancer and liver metastasis 2017 ·Vaccine ·Tyler J. Goodwin, Leaf Huang	62
9	Quercetin Remodels the Tumor Microenvironment To Improve the Permeation, Retention, and Antitumor Effects of Nanoparticles 2017 ·ACS Nano ·Kaili Hu, Lei Miao, Tyler J. Goodwin, Jun Li, Qi Liu, Leaf Huang	246
10	HDAC8 inhibition modulates liver tumor microenvironment: Rationale for combined epigenetic and immunotherapy 2017 ·The Journal of Immunology ·Alfred S.L. Cheng, Yu Feng, Jingying Zhou, Weiqin Yang, (unknown), Zhiwei Chen, Tyler J. Goodwin, Rihe Liu, Leaf Huang	4
11	Transient and Local Expression of Chemokine and Immune Checkpoint Traps To Treat Pancreatic Cancer 2017 ·ACS Nano ·Lei Miao, Jingjing Li, Qi Liu, (unknown), Manisit Das, C. Michael Lin, Tyler J. Goodwin, (unknown), Rihe Liu, Leaf Huang	117
12	Facile Fabrication of Tumor Redox‐Sensitive Nanoassemblies of Small‐Molecule Oleate Prodrug as Potent Chemotherapeutic Nanomedicine 2016 ·Small ·Cong Luo, Jin Sun, Bingjun Sun, Dan Liŭ, Lei Miao, Tyler J. Goodwin, Leaf Huang, Zhonggui He	158
13	Glycoconjugated Site-Selective DNA-Methylating Agent Targeting Glucose Transporters on Glioma Cells 2016 ·Biochemistry ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Tyler J. Goodwin, Andrew L. McIver, Libero J. Bartolotti, Arthur R. Frampton, Andrea J. Bourdelais, S. Varadarajan	13
14	Local and transient gene expression primes the liver to resist cancer metastasis 2016 ·Science Translational Medicine ·Tyler J. Goodwin, Yingqiu Zhou, Sara Musetti, Rihe Liu, Leaf Huang	71
15	Nonviral Vectors 2014 ·Advances in genetics ·Tyler J. Goodwin, Leaf Huang	30
16	A New Approach for the Immunogenic Presentation of Membrane-Bound Human Colon Tumor Antigens 1982 ·Immunological Communications ·Baldwin H. Tom, Tyler J. Goodwin, Jayati Sengupta, B D Kahan, (unknown)	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact